ArticlePharmaceutics2026

Evaluating the Impact of CYP2D6 Phenotype on Fluvoxamine Pharmacokinetics in Geriatric Patients Using Physiologically Based Pharmacokinetic Modeling.

Eunjin HongPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.